DUSP1 gene polymorphisms are associated with obesity-related metabolic complications among severely obese patients and impact on gene methylation and expression

International Journal of Genomics

Volumn 2013, Issue , 2013, Pages

  Guenard F ^a,b,c   Bouchard, L ^d   Tchernof, A ^b,c   Deshaies, Y ^b,e   Hould, F S ^b   Lebel, S ^b   Marceau, P ^b   Perusse L ^a,b,c   Vohl, M C ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d CHICOUTIMI HOSPITAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; EXON; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; INTRON; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84883196918     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2013/609748     Document Type: Article

References (41)

1. Mokdad A. H., Ford E. S., Bowman B. A., Dietz W. H., Vinicor F., Bales V. S., Marks J. S., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 2003 289 1 76 79 2-s2.0-0037223174 10.1001/jama.289.1.76
2. Tirosh A., Shai I., Afek A., Dubnov-Raz G., Ayalon N., Gordon B., Derazne E., Tzur D., Shamis A., Vinker S., Rudich A., Adolescent BMI trajectory and risk of diabetes versus coronary disease. The New England Journal of Medicine 2011 364 14 1315 1325 2-s2.0-79953796176 10.1056/NEJMoa1006992
3. Lafontan M., Girard J., Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes and Metabolism 2008 34 4, part 1 317 327 2-s2.0-51649091105 10.1016/j.diabet.2008.04.001
4. Mathieu P., Poirier P., Pibarot P., Lemieux I., Després J.-P., Visceral obesity the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009 53 4 577 584 2-s2.0-64849088450 10.1161/ HYPERTENSIONAHA.108.110320
5. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696
6. Karelis A. D., St-Pierre D. H., Conus F., Rabasa-Lhoret R., Poehlman E. T., Metabolic and body composition factors in subgroups of obesity: what do we know? Journal of Clinical Endocrinology and Metabolism 2004 89 6 2569 2575 2-s2.0-2942657651 10.1210/jc.2004-0165
7. Otani H., Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidants and Redox Signaling 2011 15 7 1911 1926 2-s2.0-80051993151 10.1089/ars.2010.3739
8. Romeo G. R., Lee J., Shoelson S. E., Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 8 1771 1776
9. Teran-Garcia M., Bouchard C., Genetics of the metabolic syndrome. Applied Physiology, Nutrition, and Metabolism 2007 32 1 89 114
10. Bouchard L., Tchernof A., Deshaies Y., Marceau S., Lescelleur O., Biron S., Vohl M.-C., ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obesity Surgery 2007 17 3 372 382 2-s2.0-34247487760 10.1007/s11695-007-9067-5
11. Abraham S. M., Clark A. R., Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochemical Society Transactions 2006 34 6 1018 1023 2-s2.0-34248679869 10.1042/BST0341018
12. Kracht M., Saklatvala J., Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 2002 20 3 91 106 2-s2.0-0036435213 10.1006/cyto.2002.0895
13. Saklatvala J., Dean J., Clark A., Control of the expression of inflammatory response genes. Biochemical Society Symposium 2003 70 95 106 2-s2.0-1542390447
14. Yin Y., Terauchi Y., Solomon G. G., Aizawa S., Rangarajan P. N., Yazaki Y., Kadowaki T., Barrett J. C., Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 1998 391 6668 707 710 2-s2.0-0032510136 10.1038/35648
15. Bang Y.-J., Kwon J. H., Kang S. H., Kim J. W., Yang Y. C., Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochemical and Biophysical Research Communications 1998 250 1 43 47 2-s2.0-0032497287 10.1006/bbrc.1998.9256
16. Vicent S., Garayoa M., López-Picazo J. M., Lozano M. D., Toledo G., Thunnissen F. B. J. M., Manzano R. G., Montuenga L. M., Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clinical Cancer Research 2004 10 11 3639 3649 2-s2.0-2542637306 10.1158/1078-0432.CCR-03-0771
17. Wang H.-Y., Cheng Z., Malbon C. C., Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Letters 2003 191 2 229 237 2-s2.0-0037430452 10.1016/S0304-3835(02)00612-2
18. Calvisi D. F., Pinna F., Meloni F., Ladu S., Pellegrino R., Sini M., Daino L., Simile M. M., De Miglio M. R., Virdis P., Frau M., Tomasi M. L., Seddaiu M. A., Muroni M. R., Feo F., Pascale R. M., Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Research 2008 68 11 4192 4200 2-s2.0-49249093107 10.1158/0008-5472.CAN-07-6157
19. Rauhala H. E., Porkka K. P., Tolonen T. T., Martikainen P. M., Tammela T. L. J., Visakorpi T., Dual-specificity phosphatase 1 and serum/glucocorticoid- regulated kinase are downregulated in prostate cancer. International Journal of Cancer 2005 117 5 738 745 2-s2.0-27744566704 10.1002/ijc.21270
20. Shimada K., Nakamura M., Ishida E., Higuchi T., Tanaka M., Ota I., Konishi N., c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas. American Journal of Pathology 2007 171 3 1003 1012 2-s2.0-34548841930 10.2353/ajpath.2007.070010
21. Tsujita E., Taketomi A., Gion T., Kuroda Y., Endo K., Watanabe A., Nakashima H., Aishima S.-I., Kohnoe S., Maehara Y., Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma. Oncology 2005 69 4 342 347 2-s2.0-28644440476 10.1159/000089766
22. Marceau P., Hould F.-S., Simard S., Lebel S., Bourque R.-A., Potvin M., Biron S., Biliopancreatic diversion with duodenal switch. World Journal of Surgery 1998 22 9 947 954 2-s2.0-0031826757 10.1007/s002689900498
23. Robitaille J., Després J.-P., Pérusse L., Vohl M.-C., The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study. Clinical Genetics 2003 63 2 109 116 2-s2.0-0041630975 10.1034/j.1399-0004.2003.00026.x
24. Barrett J. C., Fry B., Maller J., Daly M. J., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 2 263 265 2-s2.0-13444269543 10.1093/bioinformatics/bth457
25. De Bakker P. I. W., Yelensky R., Pe'Er I., Gabriel S. B., Daly M. J., Altshuler D., Efficiency and power in genetic association studies. Nature Genetics 2005 37 11 1217 1223 2-s2.0-27644439141 10.1038/ng1669
26. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T., MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005 21 13 2933 2942 2-s2.0-21444443478 10.1093/bioinformatics/bti473
27. Quandt K., Frech K., Karas H., Wingender E., Werner T., Matlnd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Research 1995 23 23 4878 4884 2-s2.0-0028971143
28. Reese M. G., Eeckman F. H., Kulp D., Haussler D., Improved splice site detection in Genie. Journal of Computational Biology 1997 4 3 311 323
29. Chi H., Barry S. P., Roth R. J., Wu J. J., Jones E. A., Bennett A. M., Flavell R. A., Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2274 2279 2-s2.0-33144460185 10.1073/pnas.0510965103
30. Duncan B. B., Schmidt M. I., Pankow J. S., Ballantyne C. M., Couper D., Vigo A., Hoogeveen R., Folsom A. R., Heiss G., Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003 52 7 1799 1805 2-s2.0-0038691972
31. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001 286 3 327 334 2-s2.0-0035908632
32. Barter P., McPherson Y. R., Song K., Kesäniemi Y. A., Mahley R., Waeber G., Bersot T., Mooser V., Waterworth D., Grundy S. M., Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. Journal of Clinical Endocrinology and Metabolism 2007 92 6 2041 2045 2-s2.0-34347230553 10.1210/jc.2006-2219
33. Clarke R., Emberson J. R., Breeze E., Casas J. P., Parish S., Hingorani A. D., Fletcher A., Collins R., Smeeth L., Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. European Heart Journal 2008 29 6 800 809 2-s2.0-41149179542 10.1093/eurheartj/ehn049
34. Pineda J., Marín F., Marco P., Roldán V., Valencia J., Ruiz-Nodar J. M., Sogorb F., Lip G. Y. H., Premature coronary artery disease in young (age < 45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers. International Journal of Cardiology 2009 136 2 222 225 2-s2.0-67650770305 10.1016/j.ijcard.2008.04.020
35. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207
36. Ponomarenko J. V., Orlova G. V., Merkulova T. I., Gorshkova E. V., Fokin O. N., Vasiliev G. V., Frolov A. S., Ponomarenko M. P., rSNP-Guide: an integrated database-tools system for studying SNPs and site-directed mutations in transcription factor binding sites. Human Mutation 2002 20 4 239 248 2-s2.0-0036390088 10.1002/humu.10116
37. Grundberg E., Small K. S., Hedman A. K., Nica A. C., Buil A., Keildson S., Bell J. T., Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nature Genetics 2012 44 10 1084 1089
38. Bell J. T., Pai A. A., Pickrell J. K., Gaffney D. J., Pique-Regi R., Degner J. F., Gilad Y., Pritchard J. K., DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biology 2011 12 1, article R10 2-s2.0-78651552406 10.1186/gb-2011-12-1-r10
39. Drong A. W., Nicholson G., Hedman A. K., Meduri E., Grundberg E., Small K. S., Shin S. Y., Bell J. T., Karpe F., Soranzo N., Spector T. D., McCarthy M. I., Deloukas P., Rantalainen M., Lindgren C. M., The presence of methylation quantitative trait Loci indicates a direct genetic influence on the level of DNA methylation in adipose tissue. PLoS One 2013 8 2 e55923
40. Johnasson-Haque K., Palanichamy E., Okret S., Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. Journal of Molecular Endocrinology 2008 41 3-4 239 249 2-s2.0-55749085407 10.1677/JME-08-0015
41. Tchen C. R., Martins J. R. S., Paktiawal N., Perelli R., Saklatvala J., Clark A. R., Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. Journal of Biological Chemistry 2010 285 4 2642 2652 2-s2.0-77449099481 10.1074/jbc.M109.037309